Company Information & Drug Savings for Halozyme Therapeutics Medications

Halozyme Therapeutics is a biotechnology company developing enzyme-based drug delivery technologies. The company’s ENHANZE platform using recombinant human hyaluronidase (rHuPH20) enables subcutaneous delivery of biologics and other drugs that previously required IV administration. Halozyme partners with major pharmaceutical companies to create patient-friendly subcutaneous formulations of important medications including immunotherapies and monoclonal antibodies.

Halozyme Therapeutics

How to Contact Halozyme Therapeutics

Browse Medications Manufactured by Halozyme Therapeutics

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch